Published Date: 12-11-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Europe Needle Free Injection System Market, published by KBV research, the Europe Needle Free Injection System Market would witness market growth of 17.3% CAGR during the forecast period (2018 – 2024).
The Germany market held the dominant share in the Europe Needle Free Injection System Market by Country in 2017 and would continue to be a dominant market till 2024. The France market is expected to witness a CAGR of 18.8% during the forecast period (2018 – 2024).
The Prefilled Needle-Free Injectors segment contributed the larger revenue share to the Europe Needle Free Injection System Market by Product in 2017, and would continue to be a dominant market till 2024 and is expected to grow at a CAGR of 16.4% during the forecast period. However, Fillable Needle-Free Injectors segment is expected to grow at CAGR of 19.3% over the forecast period.
The Liquid-Based Needle Free Injectors segment held dominant share in the Europe Needle Free Injection System by Type in 2017 and would continue its dominance till 2024 and is expected to grow at a CAGR of 16.5% over the forecast period (2018-2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), National Medical Product Inc, Valeritas Inc, European Pharma Group BV, Portal Instruments, Injex Pharma AG, Bioject Medical Technologies Inc.
Europe Needle Free Injection Market Segmentation
By Site of Delivery
By End User
Unique Offerings from KBV Research